Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Not activated by EGF, TGF-a and amphiregulin. Marone R, et al. (2004) Nat Cell Biol; 6(6): 515-22. Ren Z, et al. (2002) J Biol Chem; 277(41): 38486-93.
Host
Rabbit
Immunogen
Peptide sequence around phosphorylation site of tyrosine1221/1222 (N-L-Y(p)-Y(p)-W) derived from Human HER2.
Involvement In Disease
Glioma (GLM); Ovarian cancer (OC); Lung cancer (LNCR); Gastric cancer (GASC)
Raised In
Rabbit
Reactivity
Human
Regulatory
RUO
Relevance
Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Not activated by EGF, TGF-a and amphiregulin.
Marone R, et al. (2004) Nat Cell Biol; 6(6): 515-22. Ren Z, et al. (2002) J Biol Chem; 277(41): 38486-93.
Species
Homo Sapiens (Human)
Specificity
The antibody detects endogenous level of HER2 only when phosphorylated at tyrosine1221/tyrosine1222.
Subcellular Location
Isoform 1: Cell membrane, Single-pass type I membrane protein, Cytoplasm, perinuclear region, Nucleus
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.
Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily
Tissue Specificity
Expressed in a variety of tumor tissues including primary breast tumors and tumors from small bowel, esophagus, kidney and mouth.
Buffer
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Format
liquid
Purification
Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
Purity
Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Applications
ELISA, WB, IF
Description
ELISA ; WB ; IF, WB ; ELISA ; IF
Dilution
WB
1:500-1:1000
IF
1:100-1:200
Tested Application
ELISA,WB,IF;WB:1:500-1:1000,IF:1:100-1:200
Datasheet
ELISA Protocol
Western Blotting(WB) Protocol
Immunofluorescence (IF) Protocol
Reviews of Phospho-ERBB2 (Tyr1221/Tyr1222) Antibody